Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021-Reference-Cited by-同舟云学术

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

Published:2022-11-11 Issue:6 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Kotton Camille N.¹^ORCID,Torre‐Cisneros Julián²³^ORCID,Aguado José Maria⁴,Alain Sophie⁵,Baldanti Fausto⁶,Baumann Gabriele⁷,Boeken Udo⁸,de la Calle Maria⁹,Carbone Javier¹⁰,Ciceri Fabio¹¹,Comoli Patrizia¹²,Couzi Lionel¹³,Danziger‐Isakov Lara¹⁴,Fernández‐Ruiz Mario¹⁵,Girmenia Corrado¹⁶,Grossi Paolo Antonio¹⁷,Hirsch Hans H.¹⁸,Humar Atul¹⁹,Kamar Nassim²⁰,Kotton Camille²¹,Ljungman Per²²,Malagola Michele²³,Mira Estefania²⁴,Mueller Nicolas²⁵,Sester Martina²⁶,Teng Chieh‐Lin Jerry²⁷,Torre‐Cisneros Julian²⁴,Ussetti Piedad²⁸,Westall Glen²⁹,Wolf Dana³⁰,Zamora Marty³¹,

Affiliation:

1. Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General HospitalHarvard Medical School BostonMassachusettsUSA

2. Maimónides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba (UCO) CordobaSpain

3. CIBERINFEC, ISCIII ‐ CIBER de Enfermedades InfecciosasInstituto de Salud Carlos III MadridSpain

4. University Hospital 12 de Octubre CIBERINFEC, ISCIII ‐ CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III Madrid Spain

5. French References Center for Herpes Viruses Microbiology Department CHU‐Limoges Limoges France

6. Università di Pavia, Fondazione IRCCS Policlinico San Matteo Pavia Italy

7. Landeskrankenhaus Steyr Steyr Austria

8. Department of Cardiac Surgery Medical Faculty and University Hospital Düsseldorf Heinrich‐Heine‐University Düsseldorf Germany

9. La Paz Hospital Madrid Spain

10. Hospital General Universitario Gregorio Marañón Madrid Spain

11. IRCCS San Raffaele Scientific Institute University Vita‐Salute San Raffaele Milan Italy

12. Cell Factory and Center for Advanced Therapies and Pediatric Hematology/Oncology Fondazione IRCCS Policlinico San Matteo Pavia Italy

13. Department of Nephrology Transplantation, Dialysis and Apheresis, CHU Bordeaux CNRS‐UMR 5164 ImmunoConcEpT, Bordeaux University Bordeaux France

14. Cincinnati Children's Hospital Medical Center and University of Cincinnati Cincinnati USA

15. University Hospital 12 de Octubre Madrid Spain

16. AOU Policlinico Umberto I Rome Italy

17. Università degli Studi dell'Insubria – ASST SetteLaghi Varese Italy

18. University Hospital Basel Basel Switzerland

19. University of Toronto Toronto Canada

20. Toulouse University Hospital Toulouse France

21. Massachusetts General Hospital Boston USA

22. Karolinska Hospital and Karolinska Institute Stockholm Sweden

23. University of Brescia Brescia Italy

24. Reina Sofía University Hospital Cordoba Spain

25. Universitäts Spital Zürich Zürich Switzerland

26. Universität des Saarlandes Homburg Germany

27. Taichung Veterans General Hospital Taichung Taiwan

28. Hospital Puerta de Hierro Majadahonda Madrid Spain

29. Alfred Hospital Melboune Australia

30. Hadassah University Medical Center Jerusalem Israel

31. University of Colorado at Denver Anschutz Medical Center Colorado USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13977

Reference74 articles.

1. Pathogenesis of human cytomegalovirus in the immunocompromised host

2. Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis

3. Modulation of innate and adaptive immunity by cytomegaloviruses

4. Dominance of Virus-Specific CD8 T Cells in Human Primary Cytomegalovirus Infection

5. Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of an automated real-time transcription-mediated amplification (TMA) assay for detection and quantification of cytomegalovirus DNA in different clinical specimens;Journal of Clinical Virology;2024-04

2. Using a commercially available assay that measures cytomegalovirus (CMV)-specific T-cell immunity to predict protection against CMV: A prospective, blinded clinical study;Diagnostic Microbiology and Infectious Disease;2024-02

3. Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy;Cellular Immunology;2024-01

4. Letermovir Rescue Therapy in Kidney Transplant Recipients with Refractory/Resistant CMV Disease;Journal of Clinical Medicine;2023-12-23

5. Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?;Transplant International;2023-11-07